Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Vernalis is a speciality bio-pharmaceutical company focused on products marketed to specialist neurologists. The company has two marketed products, Frova® and Apokyn®, and a development pipeline focused on neurology and central nervous system disorders. The company has eight products in clinical development and collaborations with leading, global pharmaceutical companies including Novartis, Biogen Idec and Serono. Vernalis has established a US commercial operation to promote Apokyn® and co-promote Frova® alongside its North American licensing partner, Endo Pharmaceuticals, progressing the company towards its goal of becoming a sustainable, self-funding, R&D-driven, speciality bio-pharmaceutical company. ( www.vernalis.com )
Vernalis plc
Oakdene Court 613 Reading Road
Winnersh, BERKSHIRE RG41 5UA
United Kingdom
Tel: +44 118 977 3133
Fax: +44 118 989 9300